BridgeBio Share Price

BridgeBio Share Price

NASDAQ: BBOT | Micro Cap | Healthcare
$1.80
-$0.16 (-7.93%) Last updated on 19 Nov, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

BridgeBio Stock Performance

Open
$1.95
Prev. Close
$1.96
Circuit Range
N/A
Day Range
$1.79 - $1.96
Year Range
$1.79 - $14.56
Volume
25,420
Average Traded
$1.85

BridgeBio Share Price Today

As of 19 November 2026, BridgeBio Oncology Therapeutics, Inc.'s share price is $1.80. The stock opened at $1.95, compared to its previous close of $1.96. During today's trading session, BridgeBio Oncology Therapeutics, Inc.'s share price traded between $1.79 and $1.96, with an average price of $1.88. Over the past 52 weeks, the stock has recorded a high of $14.56 and a low of $1.79. In terms of performance, BridgeBio Oncology Therapeutics, Inc.'s share price has declined by 79.91% over the last six months and is down 85.32% on a year-on-year basis.

BridgeBio Share Price Chart

Line chart of the BridgeBio price trend over the selected period. The price fell overall, ranging from 1.79 to 1.96, ending at 1.80.
$1.79$1.96
L
Show Current Price
H

BridgeBio Stock Fundamentals & Key Indicators

Market Cap
$56.06M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.14
Revenue (TTM)
$0.00
Return On Equity (TTM)
-58.47%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
11.91%

BridgeBio Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$38.80-$42.11-$56.45-$34.18
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-8.53%-34.05%39.45%

BridgeBio Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$134.04
Net Profit MarginN/A
Income ChangeN/A

BridgeBio Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets15.99
Current Assets432.4
Total Assets448.38
Non Current Liabilities2.24
Current Liabilities35.04
Total Liabilities37.29
Shareholders' Equity411.1

BridgeBio Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-113.89
Investing73.33
Financing383.4

About BridgeBio

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

BridgeBio Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.60
$1.80
-31.56%
Oct 2026
$4.06
$2.63
-35.76%
Sep 2026
$8.63
$4.09
-55.35%
Aug 2026
$8.38
$9.17
+13.21%
Jul 2026
$7.75
$8.10
+6.30%
Jun 2026
$8.66
$7.62
-14.96%
May 2026
$8.40
$8.96
+6.79%
Apr 2026
$9.06
$8.39
-6.26%
Mar 2026
$10.00
$8.95
-10.54%
Feb 2026
$11.76
$10.01
-14.85%
Jan 2026
$12.05
$11.75
-5.55%
Dec 2025
$13.12
$12.44
+1.43%

BridgeBio Share Price FAQs